🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will examine the quality of life of patients undergoing bone mar...
Status
Completed
Location
Warren G. Magnuson Clinical Center (CC)
Start Date
1999-10
Trial ID
NCT00004994
This phase I/II trial studies the side effects of fludarabine phosphate, cy...
Status
Terminated
Location
The Children's Hospital at TriStar Centennial
Start Date
2006-05-24
Trial ID
NCT00358657
The safety and tolerability of hLF 1-11 given in multiple doses has to be e...
Status
Withdrawn
Location
UMC St. Radboud
Start Date
2008-11
Trial ID
NCT00430469
Treatments Being Tested
An open-label study to assess the safety, tolerability, and efficacy of FCR...
Status
Withdrawn
Location
Georgetown University Hospital
Start Date
2012-10-15
Trial ID
NCT01649388
Treatments Being Tested
The purpose of this study is to extend the use of Tacrolimus and Sirolimus ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2006-01
Trial ID
NCT00282282
Treatments Being Tested
Cord blood (CB) transplants are an option for patients lacking an HLA ident...
Status
Completed
Location
University of Colorado School of Medicine. Anschutz Medical Campus
Start Date
2020-11-13
Trial ID
NCT04103879
Treatments Being Tested
Background: Sickle cell disease (SCD) is an inherited disorder of the bloo...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2022-05-12
Trial ID
NCT05357482
Treatments Being Tested
This open-label study aims to evaluate the safety and efficacy of umbilical...
Status
Completed
Location
CHA Bundang Medical Center, CHA University
Start Date
2012-05
Trial ID
NCT01601158
Treatments Being Tested
RATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophospham...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2005-07-28
Trial ID
NCT00309842
This is a phase trial to determine the maximum tolerated dose (MTD) of clof...
Status
Completed
Location
Indiana University Cancer Center
Start Date
2007-05
Trial ID
NCT00477542
Treatments Being Tested